Higher urinary heavy metal, phthalate and arsenic concentrations accounted for 3-19% of the population attributable risk for high blood pressure: US NHANES, 2009-2012

Hypertension Research

Volumn 37, Issue 12, 2014, Pages 1075-1081

  Shiue, Ivy ^a,b,c   Hristova, Krasimira ^d  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NATIONAL HEART HOSPITAL   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; ANTIMONY; ARSENIC; ARSONIC ACID DERIVATIVE; BARIUM; CADMIUM; CESIUM; COBALT; HEAVY METAL; LEAD; MERCURY; MOLYBDENUM; PESTICIDE; PHTHALIC ACID; PLATINUM; THALLIUM; TRIMETHYLARSINE OXIDE; TUNGSTEN; URANIUM; PHTHALIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; ATTRIBUTABLE RISK; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SEX DIFFERENCE; UNITED STATES; URINALYSIS; URINE LEVEL; VERY ELDERLY; YOUNG ADULT; ADVERSE EFFECTS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; MIDDLE AGED; NUTRITION; POPULATION; SOCIOECONOMICS; URINE;

ADULT; AGED; AGED, 80 AND OVER; ARSENIC; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; HYPERTENSION; MALE; METALS, HEAVY; MIDDLE AGED; NUTRITION SURVEYS; PHTHALIC ACIDS; POPULATION; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84925442735     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2014.121     Document Type: Article

References (45)

1. Gottlieb S. Nearly a third of US adults have high blood pressure. Br Med J 2004; 329: 531.
2. Revis NW, Zinsmeister AR, Bull R. Atherosclerosis and hypertension induction by lead and cadmium ions: an effect prevented by calcium ion. Proc Natl Acad Sci USA 1981; 78: 6494-6498.
3. Carter DE, Aposhian HV, Gandolfi AJ. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol Appl Pharmacol 2003; 193: 309-334.
4. Navas-Acien A, Silbergeld EK, Sharrett R, Calderon-Aranda E, Selvin E, Guallar E. Metals in urine and peripheral arterial disease. Environ Health Perspect 2005; 113: 164-169.
5. Shiue I. Urine phthalate concentrations are higher in people with stroke: United States National Health and Nutrition Examination Surveys (NHANES), 2001-2004. Eur J Neurol 2013; 20: 728-731.
6. Olsén L, Lind L, Lind PM. Associations between circulating levels of bisphenol A and phthalate metabolites and coronary risk in the elderly. Ecotoxicol Environ Saf 2012; 80: 179-183.
7. Rogers JM, Ellis-Hutchings RG, Grey BE, Zucker RM, Norwood J Jr, Grace CE, Gordon C, Lau C. Elevated blood pressure in offspring of rats exposed to diverse chemicals during pregnancy. Toxicol Sci 2013; 137: 436-446.
8. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2012) http://www.cdc.gov/nchs/nhanes.htm.
9. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL, Calafat AM. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 2004; 112: 331-338.
10. Mulligan KJ, Davidson TM, Caruso JA. Feasibility of the direct analysis of urine by inductively coupled argon plasma mass-spectrometry for biological monitoring of exposure to metals. J Anal At Spectrom 1990; 5: 301-306.
11. Brock JW, Yoshimura Y, Barr JR, Maggio VL, Graiser SR, Nakazawa H, Needham LL. Measurement of bisphenol A levels in human urine. J Expo Anal Environ Epidemiol 2001; 11: 323-328.
12. Calafat AM, Ye X, Wong LY, Bishop AM, Needham LL. Urinary concentrations of four parabens in the U.S. population: NHANES 2005-2006. Environ Health Perspect 2010; 118: 679-685.
13. Hill RH Jr, Shealy DB, Head SL, Williams CC, Bailey SL, Gregg M, Needham LL. Pesticide residues in urine of adults living in the United States: reference range concentrations. Environ Res 1995; 71: 99-108.
14. Hill RH Jr, Shealy DB, Head SL, Williams CC, Bailey SL, Gregg M, Baker SE, Needham LL. Determination of pesticide metabolites in human urine using an isotope dilution technique and tandem mass spectrometry. J Anal Toxicol 1995; 19: 323-329.
15. BMI Classification. World Health Organization. http://www.who.int/mediacentre/ factsheets/fs311/en/.
16. Fleiss JL. Inference about population attributable risk from cross-sectional studies. Am J Epidemiol 1979; 110: 103-104.
17. LaKind JS, Goodman M, Naiman DQ. Use of NHANES data to link chemical exposures to chronic diseases: a cautionary tale. PLoS ONE 2012; 7: e51086.
18. Expert Group on Vitamins and Minerals. Food Standard Agency, 2003. http://cot.food.gov.uk/cotreports/cotjointreps/evmreport/.
19. Dalhamn T. The effect of cobalt on blood pressure, respiration and mortality, and the use of dimercaprol (BAL) as antidote. Acta Pharmacol Toxicol (Copenh) 1953; 9: 259-266.
20. Morvai V, SzakmáryE , Tá trai E, Ungváry G, Folly G. The effects of simultaneous alcohol and cobalt chloride administration on the cardiovascular system of rats. Acta Physiol Hung 1993; 81: 253-261.
21. Sandusky GE, Henk WG, Roberts ED. Histochemistry and ultrastructure of the heart in experimental cobalt cardiomyopathy in the dog. Toxicol Appl Pharmacol. 1981; 61: 89-98.
22. Cwikel J, Abdelgani A, Goldsmith JR, Quastel M, Yevelson II. Two-year follow up study of stress-related disorders among immigrants to Israel from the Chernobyl area. Environ Health Perspect 1997; 105 (Suppl 6), 1545-1550.
23. Guéguen Y, Lestaevel P, Grandcolas L, Baudelin C, Grison S, Jourdain JR, Gourmelon P, Souidi M. Chronic contamination of rats with 137 cesium radionuclide: impact on the cardiovascular system. Cardiovasc Toxicol 2008; 8: 33-40.
24. Patterson E, Szabo B, Scherlag BJ, Lazzara R. Early and delayed afterdepolarizations associated with cesium chloride-induced arrhythmias in the dog. J Cardiovasc Pharmacol 1990; 15: 323-331.
25. Fish FA, Prakash C, Roden DM. Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators. Circulation 1990; 82: 1362-1369.
26. Ooie T, Takahashi N, Saikawa T, Iwao T, Hara M, Sakata T. Suppression of cesiuminduced ventricular tachyarrhythmias by atrial natriuretic peptide in rabbits. J Card Fail 2000; 6: 250-256.
27. DAlonzo AJ, Hess TA, Darbenzio RB, Sewter JC. Effects of intracoronary cromakalim, pinacidil, or diltiazem on cesium chloride-induced arrhythmias in anesthetized dogs under conditions of controlled coronary blood flow. J Cardiovasc Pharmacol 1993; 21: 677-683.
28. Heo Y, Parsons PJ, Lawrence DA. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol 1996; 138: 149-157.
29. Vaziri ND, Ding Y, Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther 2001; 298: 679-685.
30. Byrne JV, Hope JK, Hubbard N, Morris JH. The nature of thrombosis induced by platinum and tungsten coils in saccular aneurysms. AJNR Am J Neuroradiol 1997; 18: 29-33.
31. ATSDR Toxicological Profile for Tungsten. Draft. GA:Agency for Toxic Substances and Disease Registry, Atlanta, 2003.
32. Peuster M, Fink C, von Schnakenburg C, Hausdorf G. Dissolution of tungsten coils does not produce systemic toxicity, but leads to elevated levels of tungsten in the serum and recanalization of the previously occluded vessel. Cardiol Young 2002; 12: 229-235.
33. McCallum RI. The industrial toxicology of antimony. The Ernestine Henry lecture 1987. J R Coll Physicians Lond 1989; 23: 28-32.
34. Schnorr TM, Steenland K, Thun MJ, Rinsky RA. Mortality in a cohort of antimony smelter workers. Am J Ind Med 1995; 27: 759-770.
35. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological Profile for Antimony. U.S. Public Health Service, U.S. Department of Health and Human Services, Altanta, GA, 1992.
36. U.S. Department of Health and Human Services Hazardous Substances Data Bank (HSDB, online database). National Toxicology Information Program, National Library of Medicine, Bethesda, MD, 1993.
37. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 1995; 103: 608-612.
38. Halden RU. Plastics and Health Risks. Annu Rev Public Health 2010; 31: 179-194.
39. Heudorf U, Mersch-Sundermann V, Angerer J. Phthalates: toxicology and exposure. Int J Hyg Environ Health 2007; 210: 623-634.
40. Bisset KM, Dhopeshwarkar AS, Liao C, Nicholson RA. The G protein-coupled cannabinoid-1 (CB1) receptor of mammalian brain: Inhibition by phthalate esters in vitro. Neurochem Int 2011; 59: 706-713.
41. Osman AM, van Dartel DA, Zwart E, Blokland M, Pennings JL, Piersma AH. Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity. Reprod Toxicol 2010; 30: 322-332.
42. Abir T, Rahman B, DEste C, Farooq A, Milton AH. The association between chronic arsenic exposure and hypertension: a meta-Analysis. J Toxicol 2012; 2012: 198793.
43. Abhyankar L, Jones MR, Guallar E, Navas-Acien A. Arsenic exposure and hypertension: a systematic review. Environ Health Perspect 2012; 120: 494-500.
44. Jones MR, Tellez-Plaza M, Sharrett AR, Guallar E, Navas-Acien A. Urine arsenic and hypertension in US adults: the 2003-2008 National Health and Nutrition Examination Survey. Epidemiology 2011; 22: 153-161.
45. Kumagai Y, Pi J. Molecular basis for arsenic-induced alternation in nitric oxide production and oxidative stress: implication of endothelial dysfunction. Toxicol Appl Pharmacol 2004; 198: 450-457.